Tenormin

Known as: Tenormine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1975-2017
024619752017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A bioequivalence study of two oral formulations of 100 mg atenolol was carried out in 24 healthy volunteers following a single… (More)
Is this relevant?
1995
1995
BACKGROUND Atenolol is a cardioselective beta-blocker. Tenolol is a new formulation of atenolol, with bioequivalence to the… (More)
Is this relevant?
1994
1994
The purpose of this study was to describe the pharmacokinetics of and heart rate and blood pressure responses to (S)-atenolol… (More)
Is this relevant?
1990
1990
Nine hundred and thirty-nine patients with moderate to severe hypertension, observed for up to 10 years, were found to benefit… (More)
Is this relevant?
1980
1980
Atenolol, 50 mg, b.i.d., and propranolol, 80 mg b.i.d.,. were given to 28 patients with a presumed diagnosis of migraine, in a… (More)
Is this relevant?
1978
1978
1. The disposition and metabolism of 1-(4-carbamoyl[14C]methylphenoxy)-3-isopropylaminopan-2-ol (atenolol, Tenormin) has been… (More)
Is this relevant?
1975
1975
Atenolol (Tenormin or I.C.I. 66082) is a new beta-adrenergic blocking drug, unique in being cardio-selective and in having no… (More)
  • figure I
  • figure 2
Is this relevant?
1975
1975
Two identical studies, one comparing the effect of single doses of a new beta-adrenoceptor blocker, atenolol (Tenormin) (50 mg… (More)
Is this relevant?
1975
1975
In 11 patients with severe angina pectoris a new beta-blocking drug, atenolol (Tenormin; I.C.I.66082), was found in a double… (More)
  • table I
  • table III
Is this relevant?